Rare germline copy number variants in colorectal cancer predisposition characterized by exome sequencing analysis

1.
Gastroenterology Department, Hospital Clínic de Barcelona, August Pi i Sunyer Biomedical Research Institute, CIBER of Hepatic and Digestive Diseases, University of Barcelona, Barcelona 08036, Spain
2.
Molecular Oncology Laboratory, Hospital Clínico San Carlos, Health Research Institute of the Hospital Clínico San Carlos, Madrid 28040, Spain
3.
Gastroenterology Department, Hospital Clínic de Barcelona, August Pi i Sunyer Biomedical Research Institute, CIBER of Hepatic and Digestive Diseases, University of Barcelona, Barcelona 08036, Spain
4.
Department of Pathology, Hospital Clinic de Barcelona, Barcelona 08036, Spain
5.
Gastroenterology Department, Hospital Clínic de Barcelona, August Pi i Sunyer Biomedical Research Institute, CIBER of Hepatic and Digestive Diseases, University of Barcelona, Barcelona 08036, Spain
6.
Bioinformatics Platform, CIBER of Hepatic and Digestive Diseases, Barcelona 08036, Spain
7.
National Center of Genomic Analysis, Science Park of Barcelona, Barcelona 08028, Spain
8.
Andalusian Developmental Biology Institute, CSIC-Pablo de Olavide University-Andalusian Regional Government, Sevilla 41013, Spain
9.
Gastroenterology Department, Hospital Donostia–Biodonostia Institute, CIBER of Hepatic and Digestive Diseases, University of the Basque Country (UPV/EHU), San Sebastián 20080, Spain

More Information

Corresponding author: E-mail address: sbel@clinic.cat (Sergi Castellví-Bel)

These two authors contributed equally to this work.

摘要

These two authors contributed equally to this work.

注释:

HTML全文

参考文献(20)

[1]	Carvalho, C.M.B., Lupski, J.R. Mechanisms underlying structural variant formation in genomic disorders Nat. Rev. Genet., 17 (2016),pp. 224-238
[2]	Esteban-Jurado, C., Vila-Casadesús, M., Garre, P. et al. Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer Genet. Med., 17 (2015),pp. 131-142
[3]	Esteban-Jurado, C., Franch-Expósito, S., Muñoz, J. et al. The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer Eur. J. Hum. Genet., 24 (2016),pp. 1-5
[4]	Fernandez-Rozadilla, C., Cazier, J.-B., Tomlinson, I.P. et al. A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12 BMC Genomics, 14 (2013),p. 55
[5]	Franke, M., Ibrahim, D.M., Andrey, G. et al. Formation of new chromatin domains determines pathogenicity of genomic duplications Nature, 538 (2016),pp. 265-269
[6]	Ge, C., Wu, S., Wang, W. et al. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway Oncotarget, 6 (2015),pp. 10964-10977
[7]	Guo, Y., Sheng, Q., Samuels, D.C. et al. Comparative study of exome copy number variation estimation tools using array comparative genomic hybridization as control Biomed Res. Int. (2013),pp. 1-7
[8]	Hatakeyama, S. TRIM proteins and cancer Nat. Rev. Canc., 11 (2011),pp. 792-804
[9]	Hesson, L.B., Cooper, W.N., Latif, F. Evaluation of the 3p21.3 tumour-suppressor gene cluster Oncogene, 26 (2007),pp. 7283-7301
[10]	Iglesias, D., Fernández-Peralta, A.M., Nejda, N. et al. Cancer Genet. Cytogenet., 167 (2006),pp. 138-144
[11]	Jaeger, E., Leedham, S., Lewis, A. et al. Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1 Nat. Genet., 44 (2012),pp. 699-703
[12]	Jiang, Y., Price, D.H. Cell Cycle, 3 (2004),pp. 1151-1153
[13]	Lichtenstein, P., Holm, N.V., Verkasalo, P.K. et al. Environmental and heritable factors in the causation of cancer– analyses of cohorts of twins from Sweden, Denmark, and Finland N. Engl. J. Med., 343 (2000),pp. 78-85
[14]	Ligtenberg, M.J.L., Kuiper, R.P., Chan, T.L. et al. Nat. Genet., 41 (2009),pp. 112-117
[15]	Peng, H.X., Wu, W.Q., Yang, D.M. et al. Role of B7-H4 siRNA in proliferation, migration, and invasion of LOVO colorectal carcinoma cell line Biomed. Res. Int, 2015 (2015),p. 326981
[16]	Peters, U., Bien, S., Zubair, N. Genetic architecture of colorectal cancer Gut, 64 (2015),pp. 1623-1636
[17]	Tan, R., Wang, Y., Kleinstein, S.E. et al. An evaluation of copy number variation detection tools from whole-exome sequencing data Hum. Mutat., 35 (2014),pp. 899-907
[18]	Venkatachalam, R., Verwiel, E.T.P., Kamping, E.J. et al. Identification of candidate predisposing copy number variants in familial and early-onset colorectal cancer patients Int. J. Canc., 129 (2011),pp. 1635-1642
[19]	Wang, X., Li, X., Cheng, Y. et al. Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma Hum. Genom., 9 (2015),p. 22
[20]	Weren, R.D.A., Venkatachalam, R., Cazier, J.B. et al. J. Pathol., 236 (2015),pp. 155-164